APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Sodium

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.

Selected research

Market Outlook & Growth Opportunities

Global Montelukast Sodium Market Outlook and Growth Opportunities 2026

25 December 2025203 pages

Choose your research edition.

Industry ResearchMontelukast Sodium Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Sodium Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Montelukast Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Sodium Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Sodium Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.

The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.

This report provides an overview of the global Montelukast Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Montelukast Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Montelukast Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Montelukast Sodium Segment by Company

Morepen Laboratories

Mylan

TAPI

MSN Laboratories

Ultratech India

Aurobindo Pharma

Hetero Labs

Unimark Remedies

Jubilant Cadista

Aamorb Pharmaceuticals

Sudarshan Group

Ortin Laboratories

Vamsi Labs

Adley Group

Medopharm

Hengyuan Pharmaceutical

Arromax Pharmaceutical Technology

Lihe Wuhan New Chemical Materials

Shanghai Huachu Chemical

Montelukast Sodium Segment by Type

Montelukast Sodium Amorphous

Montelukast Sodium Crystalline

Montelukast Sodium Segment by Application

Tablets

Chewable Tablet

Oral Solution

Montelukast Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Montelukast Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Montelukast Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Montelukast Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Montelukast Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium industry.

Chapter 3: Detailed analysis of Montelukast Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Montelukast Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Montelukast Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Montelukast Sodium Industry Trends Table 2. Montelukast Sodium Industry Drivers Table 3. Montelukast Sodium Industry Opportunities and Challenges Table 4. Montelukast Sodium Industry Restraints Table 5. Global Montelukast Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Montelukast Sodium Revenue Share by Company (2021-2026) Table 7. Global Montelukast Sodium Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Montelukast Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Montelukast Sodium Average Price (USD/Kg) of Company (2021-2026) Table 10. Global Montelukast Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Montelukast Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Montelukast Sodium Company, Product Type & Application Table 13. Global Montelukast Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Montelukast Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Montelukast Sodium Amorphous Table 18. Significant Companies of Montelukast Sodium Crystalline Table 19. Global Montelukast Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Montelukast Sodium Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Montelukast Sodium Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Montelukast Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Montelukast Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Montelukast Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Montelukast Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Montelukast Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Montelukast Sodium Sales Value Share by Type (2021-2026) Table 28. Global Montelukast Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tablets Table 30. Significant Companies of Chewable Tablet Table 31. Significant Companies of Oral Solution Table 32. Global Montelukast Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Montelukast Sodium Sales Volume by Application (2021-2026) & (Kg) Table 34. Global Montelukast Sodium Sales Volume by Application (2027-2032) & (Kg) Table 35. Global Montelukast Sodium Sales Volume Share by Application (2021-2026) Table 36. Global Montelukast Sodium Sales Volume Share by Application (2027-2032) Table 37. Global Montelukast Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Montelukast Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Montelukast Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Montelukast Sodium Sales Value Share by Application (2021-2026) Table 41. Global Montelukast Sodium Sales Value Share by Application (2027-2032) Table 42. Global Montelukast Sodium Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Montelukast Sodium Sales by Region (2021-2026) & (Kg) Table 44. Global Montelukast Sodium Sales Market Share by Region (2021-2026) Table 45. Global Montelukast Sodium Sales by Region (2027-2032) & (Kg) Table 46. Global Montelukast Sodium Sales Market Share by Region (2027-2032) Table 47. Global Montelukast Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Montelukast Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Montelukast Sodium Sales Value Share by Region (2021-2026) Table 50. Global Montelukast Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Montelukast Sodium Sales Value Share by Region (2027-2032) Table 52. Global Montelukast Sodium Market Average Price (USD/Kg) by Region (2021-2026) Table 53. Global Montelukast Sodium Market Average Price (USD/Kg) by Region (2027-2032) Table 54. Global Montelukast Sodium Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. Global Montelukast Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Montelukast Sodium Sales by Country (2021-2026) & (Kg) Table 57. Global Montelukast Sodium Sales Market Share by Country (2021-2026) Table 58. Global Montelukast Sodium Sales by Country (2027-2032) & (Kg) Table 59. Global Montelukast Sodium Sales Market Share by Country (2027-2032) Table 60. Global Montelukast Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Montelukast Sodium Sales Value Market Share by Country (2021-2026) Table 62. Global Montelukast Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Montelukast Sodium Sales Value Market Share by Country (2027-2032) Table 64. Morepen Laboratories Company Information Table 65. Morepen Laboratories Business Overview Table 66. Morepen Laboratories Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 67. Morepen Laboratories Montelukast Sodium Product Portfolio Table 68. Morepen Laboratories Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 72. Mylan Montelukast Sodium Product Portfolio Table 73. Mylan Recent Development Table 74. TAPI Company Information Table 75. TAPI Business Overview Table 76. TAPI Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 77. TAPI Montelukast Sodium Product Portfolio Table 78. TAPI Recent Development Table 79. MSN Laboratories Company Information Table 80. MSN Laboratories Business Overview Table 81. MSN Laboratories Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 82. MSN Laboratories Montelukast Sodium Product Portfolio Table 83. MSN Laboratories Recent Development Table 84. Ultratech India Company Information Table 85. Ultratech India Business Overview Table 86. Ultratech India Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 87. Ultratech India Montelukast Sodium Product Portfolio Table 88. Ultratech India Recent Development Table 89. Aurobindo Pharma Company Information Table 90. Aurobindo Pharma Business Overview Table 91. Aurobindo Pharma Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 92. Aurobindo Pharma Montelukast Sodium Product Portfolio Table 93. Aurobindo Pharma Recent Development Table 94. Hetero Labs Company Information Table 95. Hetero Labs Business Overview Table 96. Hetero Labs Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 97. Hetero Labs Montelukast Sodium Product Portfolio Table 98. Hetero Labs Recent Development Table 99. Unimark Remedies Company Information Table 100. Unimark Remedies Business Overview Table 101. Unimark Remedies Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 102. Unimark Remedies Montelukast Sodium Product Portfolio Table 103. Unimark Remedies Recent Development Table 104. Jubilant Cadista Company Information Table 105. Jubilant Cadista Business Overview Table 106. Jubilant Cadista Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 107. Jubilant Cadista Montelukast Sodium Product Portfolio Table 108. Jubilant Cadista Recent Development Table 109. Aamorb Pharmaceuticals Company Information Table 110. Aamorb Pharmaceuticals Business Overview Table 111. Aamorb Pharmaceuticals Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 112. Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio Table 113. Aamorb Pharmaceuticals Recent Development Table 114. Sudarshan Group Company Information Table 115. Sudarshan Group Business Overview Table 116. Sudarshan Group Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 117. Sudarshan Group Montelukast Sodium Product Portfolio Table 118. Sudarshan Group Recent Development Table 119. Ortin Laboratories Company Information Table 120. Ortin Laboratories Business Overview Table 121. Ortin Laboratories Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 122. Ortin Laboratories Montelukast Sodium Product Portfolio Table 123. Ortin Laboratories Recent Development Table 124. Vamsi Labs Company Information Table 125. Vamsi Labs Business Overview Table 126. Vamsi Labs Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 127. Vamsi Labs Montelukast Sodium Product Portfolio Table 128. Vamsi Labs Recent Development Table 129. Adley Group Company Information Table 130. Adley Group Business Overview Table 131. Adley Group Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 132. Adley Group Montelukast Sodium Product Portfolio Table 133. Adley Group Recent Development Table 134. Medopharm Company Information Table 135. Medopharm Business Overview Table 136. Medopharm Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 137. Medopharm Montelukast Sodium Product Portfolio Table 138. Medopharm Recent Development Table 139. Hengyuan Pharmaceutical Company Information Table 140. Hengyuan Pharmaceutical Business Overview Table 141. Hengyuan Pharmaceutical Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 142. Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio Table 143. Hengyuan Pharmaceutical Recent Development Table 144. Arromax Pharmaceutical Technology Company Information Table 145. Arromax Pharmaceutical Technology Business Overview Table 146. Arromax Pharmaceutical Technology Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 147. Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio Table 148. Arromax Pharmaceutical Technology Recent Development Table 149. Lihe Wuhan New Chemical Materials Company Information Table 150. Lihe Wuhan New Chemical Materials Business Overview Table 151. Lihe Wuhan New Chemical Materials Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 152. Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio Table 153. Lihe Wuhan New Chemical Materials Recent Development Table 154. Shanghai Huachu Chemical Company Information Table 155. Shanghai Huachu Chemical Business Overview Table 156. Shanghai Huachu Chemical Montelukast Sodium Sales (Kg), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 157. Shanghai Huachu Chemical Montelukast Sodium Product Portfolio Table 158. Shanghai Huachu Chemical Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Montelukast Sodium Distributors List Table 162. Montelukast Sodium Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Montelukast Sodium Product Image Figure 2. Global Montelukast Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Montelukast Sodium Sales (2021-2032) & (Kg) Figure 5. Global Montelukast Sodium Sales Average Price (USD/Kg) & (2021-2032) Figure 6. Global Montelukast Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Montelukast Sodium Amorphous Image Figure 10. Montelukast Sodium Crystalline Image Figure 11. Global Montelukast Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Montelukast Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Montelukast Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Montelukast Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Montelukast Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Montelukast Sodium Sales Value Share by Type (2021-2032) Figure 17. Tablets Image Figure 18. Chewable Tablet Image Figure 19. Oral Solution Image Figure 20. Global Montelukast Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Montelukast Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Montelukast Sodium Sales Volume Share by Application (2021-2032) Figure 23. Global Montelukast Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Montelukast Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Montelukast Sodium Sales Value Share by Application (2021-2032) Figure 26. Global Montelukast Sodium Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global Montelukast Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Montelukast Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Montelukast Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 31. North America Montelukast Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Montelukast Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Montelukast Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 37. South America Montelukast Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Montelukast Sodium Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Montelukast Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Montelukast Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Montelukast Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Montelukast Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Montelukast Sodium Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Montelukast Sodium Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Montelukast Sodium Amorphous
  • Montelukast Sodium Crystalline
Applications
  • Tablets
  • Chewable Tablet
  • Oral Solution
Companies covered
  • Morepen Laboratories
  • Mylan
  • TAPI
  • MSN Laboratories
  • Ultratech India
  • Aurobindo Pharma
  • Hetero Labs
  • Unimark Remedies
  • Jubilant Cadista
  • Aamorb Pharmaceuticals
  • Sudarshan Group
  • Ortin Laboratories
  • Vamsi Labs
  • Adley Group
  • Medopharm
  • Hengyuan Pharmaceutical
  • Arromax Pharmaceutical Technology
  • Lihe Wuhan New Chemical Materials
  • Shanghai Huachu Chemical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Montelukast Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Montelukast Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Montelukast Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Montelukast Sodium Market Dynamics
  1. 2.1 Montelukast Sodium Industry Trends
  2. 2.2 Montelukast Sodium Industry Drivers
  3. 2.3 Montelukast Sodium Industry Opportunities and Challenges
  4. 2.4 Montelukast Sodium Industry Restraints
3 Montelukast Sodium Market by Company
  1. 3.1 Global Montelukast Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Montelukast Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Montelukast Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Montelukast Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Montelukast Sodium Company Ranking (2024-2026)
  6. 3.6 Global Montelukast Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Montelukast Sodium Company Product Type and Application
  8. 3.8 Global Montelukast Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Montelukast Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Montelukast Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Montelukast Sodium Market by Type
  1. 4.1 Montelukast Sodium Type Introduction
  2. 4.1.1 Montelukast Sodium Amorphous
  3. 4.1.2 Montelukast Sodium Crystalline
  4. 4.2 Global Montelukast Sodium Sales Volume by Type
  5. 4.2.1 Global Montelukast Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Montelukast Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Montelukast Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Montelukast Sodium Sales Value by Type
  9. 4.3.1 Global Montelukast Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Montelukast Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Montelukast Sodium Sales Value Share by Type (2021-2032)
5 Montelukast Sodium Market by Application
  1. 5.1 Montelukast Sodium Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Chewable Tablet
  4. 5.1.3 Oral Solution
  5. 5.2 Global Montelukast Sodium Sales Volume by Application
  6. 5.2.1 Global Montelukast Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Sodium Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Montelukast Sodium Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Montelukast Sodium Sales Value by Application
  10. 5.3.1 Global Montelukast Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Montelukast Sodium Sales Value by Application (2021-2032)
  12. 5.3.3 Global Montelukast Sodium Sales Value Share by Application (2021-2032)
6 Montelukast Sodium Regional Sales and Value Analysis
  1. 6.1 Global Montelukast Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Montelukast Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Montelukast Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Montelukast Sodium Sales by Region (2027-2032)
  5. 6.3 Global Montelukast Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Montelukast Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Montelukast Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Montelukast Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Montelukast Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Montelukast Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Montelukast Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Montelukast Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Montelukast Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Montelukast Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Montelukast Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Montelukast Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Montelukast Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Montelukast Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Montelukast Sodium Sales Value Share by Country, 2025 VS 2032
7 Montelukast Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Montelukast Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Montelukast Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Montelukast Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Montelukast Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Montelukast Sodium Sales by Country (2027-2032)
  6. 7.4 Global Montelukast Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Montelukast Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Montelukast Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Montelukast Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Montelukast Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Montelukast Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Montelukast Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Montelukast Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Montelukast Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Montelukast Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Montelukast Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Montelukast Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Montelukast Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Montelukast Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Montelukast Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Montelukast Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Montelukast Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Montelukast Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Montelukast Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Montelukast Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Montelukast Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Montelukast Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Montelukast Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Montelukast Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Montelukast Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Montelukast Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Montelukast Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Montelukast Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Montelukast Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Montelukast Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Montelukast Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Montelukast Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Montelukast Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Morepen Laboratories
  2. 8.1.1 Morepen Laboratories Company Information
  3. 8.1.2 Morepen Laboratories Business Overview
  4. 8.1.3 Morepen Laboratories Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Morepen Laboratories Montelukast Sodium Product Portfolio
  6. 8.1.5 Morepen Laboratories Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Montelukast Sodium Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 TAPI
  14. 8.3.1 TAPI Company Information
  15. 8.3.2 TAPI Business Overview
  16. 8.3.3 TAPI Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TAPI Montelukast Sodium Product Portfolio
  18. 8.3.5 TAPI Recent Developments
  19. 8.4 MSN Laboratories
  20. 8.4.1 MSN Laboratories Company Information
  21. 8.4.2 MSN Laboratories Business Overview
  22. 8.4.3 MSN Laboratories Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MSN Laboratories Montelukast Sodium Product Portfolio
  24. 8.4.5 MSN Laboratories Recent Developments
  25. 8.5 Ultratech India
  26. 8.5.1 Ultratech India Company Information
  27. 8.5.2 Ultratech India Business Overview
  28. 8.5.3 Ultratech India Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ultratech India Montelukast Sodium Product Portfolio
  30. 8.5.5 Ultratech India Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Montelukast Sodium Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
  37. 8.7 Hetero Labs
  38. 8.7.1 Hetero Labs Company Information
  39. 8.7.2 Hetero Labs Business Overview
  40. 8.7.3 Hetero Labs Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hetero Labs Montelukast Sodium Product Portfolio
  42. 8.7.5 Hetero Labs Recent Developments
  43. 8.8 Unimark Remedies
  44. 8.8.1 Unimark Remedies Company Information
  45. 8.8.2 Unimark Remedies Business Overview
  46. 8.8.3 Unimark Remedies Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Unimark Remedies Montelukast Sodium Product Portfolio
  48. 8.8.5 Unimark Remedies Recent Developments
  49. 8.9 Jubilant Cadista
  50. 8.9.1 Jubilant Cadista Company Information
  51. 8.9.2 Jubilant Cadista Business Overview
  52. 8.9.3 Jubilant Cadista Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jubilant Cadista Montelukast Sodium Product Portfolio
  54. 8.9.5 Jubilant Cadista Recent Developments
  55. 8.10 Aamorb Pharmaceuticals
  56. 8.10.1 Aamorb Pharmaceuticals Company Information
  57. 8.10.2 Aamorb Pharmaceuticals Business Overview
  58. 8.10.3 Aamorb Pharmaceuticals Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Aamorb Pharmaceuticals Montelukast Sodium Product Portfolio
  60. 8.10.5 Aamorb Pharmaceuticals Recent Developments
  61. 8.11 Sudarshan Group
  62. 8.11.1 Sudarshan Group Company Information
  63. 8.11.2 Sudarshan Group Business Overview
  64. 8.11.3 Sudarshan Group Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sudarshan Group Montelukast Sodium Product Portfolio
  66. 8.11.5 Sudarshan Group Recent Developments
  67. 8.12 Ortin Laboratories
  68. 8.12.1 Ortin Laboratories Company Information
  69. 8.12.2 Ortin Laboratories Business Overview
  70. 8.12.3 Ortin Laboratories Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ortin Laboratories Montelukast Sodium Product Portfolio
  72. 8.12.5 Ortin Laboratories Recent Developments
  73. 8.13 Vamsi Labs
  74. 8.13.1 Vamsi Labs Company Information
  75. 8.13.2 Vamsi Labs Business Overview
  76. 8.13.3 Vamsi Labs Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vamsi Labs Montelukast Sodium Product Portfolio
  78. 8.13.5 Vamsi Labs Recent Developments
  79. 8.14 Adley Group
  80. 8.14.1 Adley Group Company Information
  81. 8.14.2 Adley Group Business Overview
  82. 8.14.3 Adley Group Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Adley Group Montelukast Sodium Product Portfolio
  84. 8.14.5 Adley Group Recent Developments
  85. 8.15 Medopharm
  86. 8.15.1 Medopharm Company Information
  87. 8.15.2 Medopharm Business Overview
  88. 8.15.3 Medopharm Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Medopharm Montelukast Sodium Product Portfolio
  90. 8.15.5 Medopharm Recent Developments
  91. 8.16 Hengyuan Pharmaceutical
  92. 8.16.1 Hengyuan Pharmaceutical Company Information
  93. 8.16.2 Hengyuan Pharmaceutical Business Overview
  94. 8.16.3 Hengyuan Pharmaceutical Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hengyuan Pharmaceutical Montelukast Sodium Product Portfolio
  96. 8.16.5 Hengyuan Pharmaceutical Recent Developments
  97. 8.17 Arromax Pharmaceutical Technology
  98. 8.17.1 Arromax Pharmaceutical Technology Company Information
  99. 8.17.2 Arromax Pharmaceutical Technology Business Overview
  100. 8.17.3 Arromax Pharmaceutical Technology Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Arromax Pharmaceutical Technology Montelukast Sodium Product Portfolio
  102. 8.17.5 Arromax Pharmaceutical Technology Recent Developments
  103. 8.18 Lihe Wuhan New Chemical Materials
  104. 8.18.1 Lihe Wuhan New Chemical Materials Company Information
  105. 8.18.2 Lihe Wuhan New Chemical Materials Business Overview
  106. 8.18.3 Lihe Wuhan New Chemical Materials Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Lihe Wuhan New Chemical Materials Montelukast Sodium Product Portfolio
  108. 8.18.5 Lihe Wuhan New Chemical Materials Recent Developments
  109. 8.19 Shanghai Huachu Chemical
  110. 8.19.1 Shanghai Huachu Chemical Company Information
  111. 8.19.2 Shanghai Huachu Chemical Business Overview
  112. 8.19.3 Shanghai Huachu Chemical Montelukast Sodium Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Shanghai Huachu Chemical Montelukast Sodium Product Portfolio
  114. 8.19.5 Shanghai Huachu Chemical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Montelukast Sodium Value Chain Analysis
  2. 9.1.1 Montelukast Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Montelukast Sodium Sales Mode & Process
  6. 9.2 Montelukast Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Montelukast Sodium Distributors
  9. 9.2.3 Montelukast Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst